Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Abstract Directory, Saturday, May 18, 2013<br />
Saturday, May 18, 2013<br />
Poster Session III, continued<br />
3:45 PM - 5:45 PM<br />
Room: Exhibit Hall C/D<br />
Adenovirus and Other DNA Virus Vectors II<br />
556<br />
Enhanced Anti-Tumor Eficacy by Oncolytic Adenovirus<br />
Using a Stimuli Responsive Block Copolymer<br />
mPEG-b-Poly(His)<br />
Joung-Woo Choi, You Han Bae, Chae-Ok Yun.<br />
557<br />
Distinct Integration Proiles after Sleeping Beauty<br />
Transposase-Mediated Somatic Integration from AAV<br />
and Adenoviral Vectors<br />
Wenli Zhang, Christina Rauschhuber, Martin Haeusl, Nadine<br />
Muether, Anja Ehrhardt.<br />
558<br />
Screening and Characterization <strong>of</strong> Alternative<br />
Adenovirus Serotypes with Enhanced Virus-<br />
Lateralization Ability In Vitro for Improved Antitumor<br />
Eficacy<br />
Junji Uchino, David T. Curiel, Hideyo Ugai.<br />
559<br />
Improved Animal Models for Testing <strong>Gene</strong> or <strong>Cell</strong><br />
Therapies for Atherosclerosis<br />
Liang Du, Jingwan Zhang, David Dichek.<br />
560<br />
Liver Retargeting <strong>of</strong> Adenovirus Using Robo4 Promoter<br />
and Hexon Substitution<br />
Sergey A. Kaliberov, Lyudmila N. Kaliberova, Zhi Hong Lu,<br />
Meredith A. Preuss, Justin A. Barnes, Cecil R. Stockard, William E.<br />
Grizzle, Jeffrey M. Arbeit, David T. Curiel.<br />
561 (Moved to Poster Session I after Abstract 138)<br />
Lister Strain Vaccinia Virus Demonstrates Favourable<br />
Anti-Tumor Eficacy and Tumor-Selectivity Compared<br />
to Western Reserve Strain<br />
Jonathan Hughes, Pengju Wang, Ghassan Alusi, Vipul Bhakta,<br />
Yongchao Chu, Hailiang Shi, Iain McNeish, Andrea McCart, Istvan<br />
Fodor, Nicholas Lemoine, Yaohe Wang.<br />
562<br />
Development <strong>of</strong> a Novel Vaccine Vector Based on<br />
Synthesized Adenovirus Genome<br />
Yong Yang, Chao Zhang, Xiang Wang, Yudan Chi, Dongming Zhou.<br />
563<br />
Construction <strong>of</strong> a Novel Bicistronic Adenoviral Vector<br />
Feilong Jie, Shengyao Wang, Jie Luo, Na Zhang, Jingang Zhang,<br />
Hongwei Li.<br />
564<br />
Ciproloxacin Regulates Negatively Egr-1<br />
Transcriptional Activity in Human Primary Tenocytes<br />
Transduced with Ad-Egr-1/Luc<br />
Francisco Martinez-F, Araceli Barrera-Lopez, Hugo Sandoval-<br />
Zamora, Karina Guzman-M, Alejandro Jimenez-Orozco, Christian Y.<br />
Lomeli-R, David T. Curiel, Rebecca E. Franco-Bourland.<br />
DNA Vectorology & <strong>Gene</strong> Targeting II<br />
565<br />
A Placebo Controlled Phase IIb Clinical Study<strong>of</strong><br />
Tissue<strong>Gene</strong>-C (TG-C) in Patients with Osteoarthritis<br />
Jung Jong Cho, Tae Won Kim, Yeo Myeong Park, Eu <strong>Gene</strong> Jeong,<br />
Moon Jong Noh, Kwan Hee Lee, Bum Sup Lee.<br />
566<br />
A Novel Oncolytic HSV Design Based on the Common<br />
Over-Expression <strong>of</strong> miR-21 in Tumors<br />
Marco Marzulli, Lucia Mazzacurati, Bonnie Reinhart, Mark E.<br />
Hatley, Joseph C. Glorioso, Paola Grandi, Justus B. Cohen.<br />
567<br />
Comparing the Activity <strong>of</strong> TALENs Constructed with<br />
Different Guanine-Targeting RVDs<br />
Yanni Lin, Thomas J. Cradick, Eli J. Fine, Gang Bao.<br />
568<br />
In Vivo Cleavage <strong>of</strong> Transgene Donors Promotes<br />
Nuclease-Mediated Targeted Integration<br />
Sandra Cristea, Yevgeniy Freyvert, Yolanda Santiago, Michael C.<br />
Holmes, Fyodor D. Urnov, Philip D. Gregory, Gregory J. Cost.<br />
569<br />
Helper Independent Self-Inactivating Chimeric<br />
PiggyBac Transposases for Genomic Targeting in<br />
Human <strong>Cell</strong>s<br />
Jesse B. Owens, Johann Urschitz, Ilko Stoytchev, Stefan Moisyadi.<br />
570<br />
Eficacy with Extremely Low Doses <strong>of</strong> Plasmid DNA<br />
Using Small Molecule Targeted Delivery <strong>of</strong> Bilamellar<br />
Invaginated Vesicles (BIVs) to Melanoma Tumor<br />
Xenografts<br />
Nancy S. Templeton, Li Chen, Connor Phalon, Phillip B. Maples,<br />
Neil Senzer, John Nemunaitis.<br />
571<br />
Zinc Finger Nuclease-Based <strong>Gene</strong> <strong>Therapy</strong> for Arginase<br />
I Deiciency as a Model for Curing Single-Enzyme Urea<br />
Cycle Disorders<br />
Ragini Bhargava, Hana Park, Sarah Novic<strong>of</strong>f, Alok V. Joglekar,<br />
Donald B. Kohn, Gerald S. Lipshutz.<br />
572<br />
Poly(2-Dimethylaminoethyl Methacrylate)-<br />
Functionalized Graphene Oxide Nanolakes for Eficient<br />
siRNA Delivery<br />
Jung Eun Lee, Min Sang Lee, Jeong A. Nam, Nak Won Kim, Sung<br />
Young Park, Ji Hoon Jeong.<br />
130<br />
<strong>Final</strong> <strong>Program</strong> SALT LAKE CITY, UTAH May 15–18, 2013
Change language